FDA Commissioner McClellan
This article was originally published in The Tan Sheet
Executive Summary
White House health and economic advisor Mark McClellan, MD/PhD, unanimously confirmed by Senate Oct. 17 after Health Committee member Jeff Bingaman (D-N.M.) lifted hold on nomination (1"The Tan Sheet" Oct. 14, 2002, p. 7). Confirmation comes 21 months after former Commissioner Jane Henney, MD, left office. Although no swearing-in date had been set as of Oct. 18, FDA's Science Board meeting in Rockville, Md. Oct. 25 could mark his first public appearance as commissioner. Meeting agenda lists introductory remarks to be given by McClellan "pending confirmation." Meeting will include discussion of CFSAN counterterrorism efforts, CDER's drug GMP initiative...
You may also be interested in...
FDA's Next Commissioner: Will Trump Follow Hamburg Or McClellan 'Schedule'?
Nothing seems conventional about this presidency, but history suggests a nomination may not arrive for another month or longer, and thereafter confirmation could be swift.
FDA commissioner
White House health and economic advisor Mark McClellan, PhD/MD, sworn in as FDA commissioner Nov. 14. McClellan was unanimously confirmed by the Senate Oct. 17 (1"The Tan Sheet" Oct. 21, 2002, In Brief). During groundbreaking ceremony for new FDA facilities in White Oak, Md., McClellan delivered his first official speech as commissioner, stressing the importance of employee morale, recruitment and retention...
McClellan to start after elections
Incoming FDA Commissioner Mark McClellan, MD/PhD, will be sworn in and start at FDA Nov. 8. Currently a White House health policy advisor, McClellan was cleared by the Senate Oct. 17 (1"The Tan Sheet" Oct. 21, 2002, In Brief)...